Koninklijke Philips N.V. logo

Koninklijke Philips N.V. (PHG)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
25. 35
-0.08
-0.31%
$
25.12B Market Cap
- P/E Ratio
1% Div Yield
867,896 Volume
1.37 Eps
$ 25.43
Previous Close
Add Transaction
Day Range
25.25 25.64
Year Range
21.95 33.44
Want to track PHG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term

Why Royal Philips (PHG) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 3 months ago
Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Philips Posts Earnings in Q4, Revenues Increase Y/Y, Shares Dip

Philips Posts Earnings in Q4, Revenues Increase Y/Y, Shares Dip

PHG swings to Q4 profit as comparable sales jump 7% and orders rise, but shares fall despite double-digit EBITA growth and 2026 outlook.

Zacks | 3 months ago
Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript

Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript

Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 months ago
Philips Proposes Extension of CEO's Tenure After Guiding For Higher Profitability

Philips Proposes Extension of CEO's Tenure After Guiding For Higher Profitability

Roy Jakobs has headed Philips since October 2022 and the company said it would put his re-appointment to shareholders later this year.

Wsj | 3 months ago
Koninklijke Philips: Macro Set-Up Favors And AI Tailwinds

Koninklijke Philips: Macro Set-Up Favors And AI Tailwinds

Philips benefits from sector-wide valuation tailwinds, anticipated MedTech revival in 2026, and accelerating organic revenue growth. AI integration, highlighted by the SpectraWAVE acquisition, is set to drive higher growth, margin expansion, and capital efficiency for PHG. European healthcare has lagged for three years, leaving valuations attractive; we expect 2026 to mark a re-engagement phase for generalists and a healthier backdrop for the sector.

Seekingalpha | 4 months ago
Philips: Waiting Comfortably For Upside From Healthcare AI Leadership

Philips: Waiting Comfortably For Upside From Healthcare AI Leadership

Philips N.V. (PHG) is rated a conservative 'Buy' with a maintained price target, reflecting 20%+ annualized upside potential. PHG's leadership in imaging, healthcare AI, and a strong moat in diagnosis and treatment underpin the investment case despite historical missteps. Litigation resolution, productivity initiatives, and a 40–50% dividend payout target support margin expansion and forward earnings growth.

Seekingalpha | 5 months ago
Polarean shares jump 12% after Philips clears its Xenon lung-scan tech

Polarean shares jump 12% after Philips clears its Xenon lung-scan tech

Polarean Imaging PLC's (AIM:POLX, OTC:PLLWF) stock popped 12% to 0.14p on Monday after the company cleared a major technical hurdle in its bid to get Xenon-based lung scans into more hospitals. Philips has signed off on Polarean's XENOVIEW 3T chest coil, confirming it plays nicely with the Dutch giant's next wave of 3-tesla MRI scanners.

Proactiveinvestors | 6 months ago
Polarean coil cleared for use on Philips' newest MRI scanners

Polarean coil cleared for use on Philips' newest MRI scanners

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has cleared a key hurdle in its push to expand the reach of its Xenon-based lung scans, after its dedicated chest coil passed compatibility testing with Philips' latest magnetic resonance imaging systems. The company said Philips had completed its own validation of the XENOVIEW 3T Chest Coil, which was cleared by the US Food and Drug Administration last year.

Proactiveinvestors | 6 months ago
Koninklijke Philips N.V. (PHG) Q3 2025 Earnings Call Transcript

Koninklijke Philips N.V. (PHG) Q3 2025 Earnings Call Transcript

Koninklijke Philips N.V. ( PHG ) Q3 2025 Earnings Call November 4, 2025 4:00 AM EST Company Participants Durga Doraisamy - Head of Investor Relations Roy Jakobs - President, CEO & Chairman of the Board of Management Charlotte Hanneman - Executive VP, CFO & Member of Board of Management Conference Call Participants Julien Dormois - Jefferies LLC, Research Division Edward Ridley-Day - Rothschild & Co Redburn, Research Division Hugo Solvet - BNP Paribas, Research Division Hassan Al-Wakeel - Barclays Bank PLC, Research Division David Adlington - JPMorgan Chase & Co, Research Division Graham Doyle - UBS Investment Bank, Research Division Veronika Dubajova - Citigroup Inc., Research Division Richard Felton - Goldman Sachs Group, Inc., Research Division Wim Gille - ABN AMRO Bank N.V.

Seekingalpha | 7 months ago
Philips Expects Full-Year Profitability to Land at Upper-End of Range

Philips Expects Full-Year Profitability to Land at Upper-End of Range

Sales growth and productivity measures at the health-technology company lifted earnings in the third quarter.

Wsj | 7 months ago
Philips reports 3% rise in quarterly sales

Philips reports 3% rise in quarterly sales

Dutch medical technology company Philips reported third-quarter revenue in line with analysts' expectations un Tuesday, citing a strong performance in North America.

Reuters | 7 months ago
Loading...
Load More